FIGURE 4.
Subgroup analysis of OS between patients in the IO+C and C groups. (a) Male subgroup. (b) Female subgroup. (c) Age ≤ 65 subgroup. (d) Bone metastasis subgroup. (e) Adrenal metastasis subgroup. (f) EGFR exon19 del mutation subgroup. (g) Third‐line treatment subgroup